Wednesday, August 20, 2025 8/20/2025

Dual-wavelength endoscopic Raman probe for eosinophilic esophagitis

Award Number: R01DK132338
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2022
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

Dual-wavelength endoscopic Raman probe for eosinophilic esophagitis - Project Summary Eosinophilic esophagitis (EoE) is a chronic inflammatory disease affecting the esophagus, and one of the most common causes of vomiting, feeding and swallowing difficulties, including esophageal food impaction in children. EoE is difficult to diagnose and distinguish from other common esophageal diseases in real-time using white light endoscopic imaging of the esophagus conducted via an esophagogastroduodenoscopy (EGD) procedure. Therefore, clinicians rely on multiple random esophageal biopsies which is obtained during this procedure for histologic confirmation (gold standard). However, since EoE is a patchy disease even the multiple biopsies may not yield accurate results. This can lead to a delay in diagnosis and ineffective treatment, and result in preventable complications such as esophageal remodeling requiring surgical interventions. As such there is an urgent need to develop alternative diagnostic tools which can quickly survey more regions of the esophagus, in situ, and provide tissue-specific inflammatory biomarker information for real-time identification of EoE. Raman spectroscopy (RS) is one such technology that can provide a solution as it relies on light interaction with molecules to provide a unique “fingerprint” of the biochemical and molecular composition of a specimen within seconds. Therefore, RS via an endoscope is uniquely suited for real-time biochemical assessment of active EoE. This proposal, presents the development and assessment of a depth specific dual-wavelength Raman endoscope to characterize both biochemical and water changes within the esophagus as it relates to active EoE. To accomplish these goals, Raman biomarkers will be characterized and identified spatially and correlated with known biomarkers of EoE in vivo as well as ex vivo. Computational modeling will be performed using a modified Monte Carlo simulation to optimize probe design based on tissue optical properties. Ex vivo non-linear imaging coupled with Raman maps will be performed on a subset of biopsies, obtained during the EGD procedures, to further study the spatial distribution of key biomarkers and help guide the endoscopic Raman probe design. This probe will be evaluated using optical tissue phantoms and in vivo patient measurements. Finally, a machine learning classification algorithm will be optimized and evaluated to provide a mechanism by which in vivo RS spectra can be classified into active EoE, inactive EoE, GERD (i.e., acid reflux disease) and other non-EoE control. Furthermore, we aim to track patient’s response to treatment and assess Raman spectral changes over time to determine the feasibility of using RS to provide a predictive treatment outcome model. The successful completion of this proposal will yield a novel diagnostic tool for real-time detection and monitoring of EoE in pediatric cases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $405,624 )
2025	2025	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	6/13/2025	NON-COMPETING CONTINUATION	$405,624
														Subtotal = $405,624

Issue Date FY: 2024 ( Subtotal = $389,733 )
2024	2024	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	6/28/2024	NON-COMPETING CONTINUATION	$389,733
														Subtotal = $389,733

Issue Date FY: 2023 ( Subtotal = $414,770 )
2023	2023	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	5/18/2023	NON-COMPETING CONTINUATION	$414,770
														Subtotal = $414,770

Issue Date FY: 2022 ( Subtotal = $448,359 )
2022	2022	VANDERBILT UNIVERSITY, THE	110 21ST AVENUE S STE 800	NASHVILLE	TN	37203	DAVIDSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	6/24/2022	NEW	$448,359
														Subtotal = $448,359

Grand Total All Awards = $1,658,486

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Dual-wavelength endoscopic Raman probe for eosinophilic esophagitis

Award Number: R01DK132338

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2022

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer